ONCOGENEX PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ONCOGENEX PHARMACEUTICALS IN CALL, CUSIP 68230A906.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ONCOGENEX PHARMACEUTICALS IN CALL, CUSIP 68230A906.